WeightWatchers is shaking up its leadership. WW International on Friday announced that CEO Sima Sistani would leave her role effective immediately. Tara Comonte, a WeightWatchers board member and form ...

You might be able to negotiate a lower medical bill, similar to how you reduced the price of your cable or internet bill.

WW International Inc. ousted Chief Executive Officer Sima Sistani after a tumultuous two-and-a-half year tenure at the diet ...

An emerging market for compounded weight loss injections that mimic brand-name drugs such as Ozempic, Wegovy, Mounjaro and ...

Semaglutide, the underlying drug marketed as Ozempic and Wegovy, works by mimicking a hormone that triggers the body to feel ...

Ongoing shortages of popular weight loss and diabetes drugs in the U.S. have spurred fierce competition between established ...

Employers that cover GLP-1s are partnering with vendors to design benefits and manage lifestyle programs, but the "jury is ...

With Medicare now covering semaglutide for people with obesity and cardiovascular disease who don't have diabetes, a study looks at who that might include, depending on what cutoffs prescription plans ...

Novo Nordisk's weight loss drug Wegovy could face Medicare price negotiations next. Meanwhile, Particle Health files an ...

A key study used in securing FDA approval for Wegovy as a lifetime medication for weight loss was based on patients using the ...

Millions of older Americans with obesity could potentially get Medicare's help with the hefty price of a weight-loss medication in order to reduce their high risk of heart problems.

Many people are doing an end-run around their doctor's office, reaching out to potentially unreliable sources that promise to ...